Published in Chest on June 01, 2015
Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak. Eur J Clin Microbiol Infect Dis (2015) 1.22
Caring for Critically Ill Patients Infected With the Ebola Virus: Logistic and Human Challenges. Chest (2015) 1.07
Critical Care Medicine and Infectious Diseases: An Emerging Combined Subspecialty in the United States. Clin Infect Dis (2015) 0.85
Ebola virus disease and critical illness. Crit Care (2016) 0.82
Caring for Critically Ill Ebola Virus Disease Patients With One Hand Tied Behind Your Back. Crit Care Med (2015) 0.75
Response. Chest (2015) 0.75
High-Containment Pathogen Preparation in the Intensive Care Unit. Infect Dis Clin North Am (2017) 0.75
Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet (1977) 9.23
Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med (2014) 4.79
A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57
Ebola virus disease in West Africa--clinical manifestations and management. N Engl J Med (2014) 3.73
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet (2014) 2.93
Caring for critically ill patients with ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med (2014) 2.90
Ethical guidance on the use of life-sustaining therapies for patients with Ebola in developed countries. Ann Intern Med (2014) 2.19
Addressing Ebola-related stigma: lessons learned from HIV/AIDS. Glob Health Action (2014) 1.96
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol (2015) 1.91
Successful delivery of RRT in Ebola virus disease. J Am Soc Nephrol (2014) 1.87
Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep (1989) 1.61
Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis (1986) 1.61
When pestilence prevails...physician responsibilities in epidemics. Am J Bioeth (2004) 1.47
Cardiopulmonary resuscitation in patients with the acquired immunodeficiency syndrome. A prospective study. Arch Intern Med (1988) 1.46
Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One (2012) 1.44
Protecting health care workers from Ebola: personal protective equipment is critical but is not enough. Ann Intern Med (2014) 1.31
ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med (1986) 1.24
Pneumocystis carinii pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units. Am Rev Respir Dis (1991) 1.23
Cluster of Ebola cases among Liberian and U.S. health care workers in an Ebola treatment unit and adjacent hospital -- Liberia, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.20
Attitudes of BCLS instructors about mouth-to-mouth resuscitation during the AIDS epidemic. Ann Emerg Med (1990) 1.15
Protecting health care workers from SARS and other respiratory pathogens: organizational and individual factors that affect adherence to infection control guidelines. Am J Infect Control (2005) 1.06
The reluctance of house staff to perform mouth-to-mouth resuscitation in the inpatient setting: what are the considerations? Resuscitation (1994) 1.03
Determinants of physician reluctance to perform mouth-to-mouth resuscitation. J Clin Epidemiol (2000) 0.99
Preparing for critical care services to patients with Ebola. Ann Intern Med (2014) 0.98
Basic-CPR and AIDS: are volunteer life-savers prepared for a storm? Resuscitation (1996) 0.92
Standards for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). 3. Advanced life support. JAMA (1974) 0.89
Standards for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). II. Basic life support. JAMA (1974) 0.88
Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong. J Thorac Dis (2013) 0.85
Standards for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). I. Introduction. JAMA (1974) 0.85
Improved outcomes in intensive care units for AIDS-related Pneumocystis carinii pneumonia: 1987-1991. J Acquir Immune Defic Syndr (1993) 0.83
Risk of infection during CPR training and rescue: supplemental guidelines. The Emergency Cardiac Care Committee of the American Heart Association. JAMA (1989) 0.81
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol (2005) 7.91
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A (2005) 5.21
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog (2007) 4.82
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood (2002) 3.70
Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom (2004) 3.52
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS (2006) 2.71
Bundled care for septic shock: an analysis of clinical trials. Crit Care Med (2010) 2.57
Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med (2002) 2.47
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol (2003) 2.36
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood (2008) 2.27
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med (2016) 2.09
Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med (2012) 2.08
Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood (2004) 2.06
A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell (2012) 2.04
Forging a critical alliance: Addressing the research needs of the United States critical illness and injury community. Crit Care Med (2009) 2.03
Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. J Infect Dis (2010) 2.03
In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest (2005) 1.96
Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols. Crit Care Med (2007) 1.88
Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol (2009) 1.84
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood (2004) 1.82
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest (2005) 1.82
Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials (2010) 1.75
High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med (2002) 1.74
Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proc Natl Acad Sci U S A (2011) 1.67
Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials (2008) 1.65
Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med (2012) 1.64
Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics (2006) 1.58
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. J Infect Dis (2001) 1.54
Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review. Crit Care Med (2014) 1.49
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47
The Fourth National Institutes of Health Symposium on the Functional Genomics of Critical Injury: Surviving stress from organ systems to molecules. Crit Care Med (2008) 1.42
Managing bloodstream infections in patients who have short-term central venous catheters. Cleve Clin J Med (2011) 1.42
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection. J Infect Dis (2004) 1.37
Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol (2008) 1.36
Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. MBio (2011) 1.36
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J Clin Invest (2014) 1.29
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages. J Virol (2003) 1.29
Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation (2007) 1.29
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials. HIV Clin Trials (2006) 1.27
Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood (2008) 1.18
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells. Blood (2002) 1.18
HIV populations are large and accumulate high genetic diversity in a nonlinear fashion. J Virol (2013) 1.17
A canine model of septic shock: balancing animal welfare and scientific relevance. Am J Physiol Heart Circ Physiol (2007) 1.17
Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics (2006) 1.15
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. J Antimicrob Chemother (2010) 1.15
Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med (2016) 1.15
Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. J Acquir Immune Defic Syndr (2002) 1.13
CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies. Clin Infect Dis (2004) 1.10
Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol (2003) 1.09
Carbon monoxide poisoning in Florida during the 2004 hurricane season. Am J Prev Med (2007) 1.08
A generic approach to pathological lung segmentation. IEEE Trans Med Imaging (2014) 1.08
Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic. Proc Natl Acad Sci U S A (2002) 1.07
Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy. J Virol (2003) 1.06
Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood (2004) 1.06
Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J Exp Med (2013) 1.03
CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation. J Infect Dis (2007) 1.02
Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr Med Res Opin (2008) 1.02
Learning shape and texture characteristics of CT tree-in-bud opacities for CAD systems. Med Image Comput Comput Assist Interv (2011) 1.02
Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother (2008) 1.00
Interferon-alpha produces significant decreases in HIV load. J Interferon Cytokine Res (2010) 0.99
CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients. J Infect Dis (2008) 0.99
Preparing for critical care services to patients with Ebola. Ann Intern Med (2014) 0.98
An official multi-society statement: the role of clinical research results in the practice of critical care medicine. Am J Respir Crit Care Med (2012) 0.97
Quality control of serum albumin depletion for proteomic analysis. Clin Chem (2007) 0.96
Influence of IFN-gamma on gene expression in normal human bronchial epithelial cells: modulation of IFN-gamma effects by dexamethasone. Physiol Genomics (2005) 0.96
Mechanisms of sepsis and insights from clinical trials. Drug Discov Today Dis Mech (2007) 0.96
A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study. PLoS Clin Trials (2006) 0.95
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial. Crit Care Med (2005) 0.95
Genetic variation and the assessment of risk in septic patients. Intensive Care Med (2006) 0.92
Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels. AIDS (2009) 0.91
Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease. Haematologica (2010) 0.90
Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med (2010) 0.89
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen. AIDS (2003) 0.89
Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells. J Pharmacol Exp Ther (2010) 0.89
Pharmacokinetics of liposomal amphotericin B in pleural fluid. Antimicrob Agents Chemother (2010) 0.89
A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda. PLoS One (2010) 0.89
The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model. Intensive Care Med (2011) 0.88
Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia. Proteomics (2010) 0.87
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease. AIDS (2014) 0.87
Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients. AIDS (2006) 0.87
Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial. AIDS (2009) 0.86
Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia. Intensive Care Med (2012) 0.85
Bacillus anthracis protease InhA regulates BslA-mediated adhesion in human endothelial cells. Cell Microbiol (2012) 0.84
Automatic detection and quantification of tree-in-bud (TIB) opacities from CT scans. IEEE Trans Biomed Eng (2012) 0.84
Analysis of naïve lung CD4 T cells provides evidence of functional lung to lymph node migration. Proc Natl Acad Sci U S A (2013) 0.84
A novel peak detection approach with chemical noise removal using short-time FFT for prOTOF MS data. Proteomics (2009) 0.83
Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock. Crit Care Med (2012) 0.83
Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients. AIDS Res Hum Retroviruses (2014) 0.83
Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection. AIDS (2006) 0.82
The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patients. J Acquir Immune Defic Syndr (2011) 0.81
The proteome of sickle cell disease: insights from exploratory proteomic profiling. Expert Rev Proteomics (2010) 0.81
Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir. AIDS Res Hum Retroviruses (2013) 0.81
The rising incidence of intentional ingestion of ethanol-containing hand sanitizers. Crit Care Med (2012) 0.81